Sign Up Today and Learn More About GATC Health Stock
Invest in or calculate the value of your shares in GATC Health or other pre-IPO companies through EquityZen's platform.
![GATC Health](https://dioguwdgf472v.cloudfront.net/media/logos/equityinvest/Company/gatchealth_logo-0b1500a92d7000b1.png)
GATC Health Stock
GATC Health is a technology company that develops predictive multi-omics advanced technology.
GATC Health is a technology company that develops predictive multi-omics advanced technology.
About GATC Health Stock
Founded
2020
Headquarters
Irvine, CA, US
Industries
Science and Engineering, Health Care, Biotechnology
GATC Health is a technology company that develops predictive multi-omics advanced technology. The company's multi-omic advanced technology platform analyzes comprehensive biological datasets (multi-omics) to provide insight into individualized, specific health risks.
GATC Health Press Mentions
Stay in the know about the latest news on GATC Health
GATC Health Establishes East Coast Presence at WVU Innovation Corporation
prnewswire • Apr 06, 2023
Former eBay Chief Architect and Fellow, Mark Palaima, Joins GATC Health as Strategic Advisor
prnewswire • Mar 16, 2022
GATC Health Names Gerald Sokol, Jr. Chief Administration Officer
prnewswire • Dec 28, 2021
Preetaman Wadhwa Joins GATC Health Corp as the Chief Marketing Officer
prnewswire • Dec 07, 2021
GATC Health Management
Leadership team at GATC Health
Chief Marketing Officer
Preetaman Wadhwa
Chief Executive Officer & Board Member
John Stroh
![Locked Features](https://dioguwdgf472v.cloudfront.net/assets/equityzen/img/public-company/locked-features.png)
Join now and verify your accreditation status to gain access to:
- GATC Health current valuation
- GATC Health stock price
- Available deals in GATC Health and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in GATC Health stock?
Accredited investors can buy pre-IPO stock in companies like GATC Health through EquityZen funds. These investments are made available by existing GATC Health shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell GATC Health stock?
Shareholders can sell their GATC Health stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."